The Indapamide Tablets, cataloged under National Stock Number 6505-01-377-1462, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Aventis Pharmaceuticals Products Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-377-1462 |
| Primary Part Number | NDC00075-0700-00 |
| Item Name | Indapamide Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Aventis Pharmaceuticals Products Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 1.250 MILLIGRAMS INDAPAMIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00075-0700-00 PRIMARY | Aventis Pharmaceuticals Products Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00070-0777-00 | 5/9 Secondary reference Usv Pharmaceutical Corp Div of William H Rorer Inc |
| LOZOL | 5/1 Secondary reference Aventis Pharmaceuticals Products Inc. |
NSN 6505-01-377-1462 is a Indapamide Tablets, manufactured by Aventis Pharmaceuticals Products Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-377-1462 has 1 manufacturer part number on file: NDC00075-0700-00 (Aventis Pharmaceuticals Products Inc.).
Key specifications for NDC00075-0700-00: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: THERAPEUTIC EQUIVALENT TO LOZOL BY RHONE-POULENC RORER. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.